Purple Biotech (KTOV) Short Interest Ratio & Short Volume → The Hard Truth About Investing For Retirement (From Insiders Exposed) (Ad) Free KTOV Stock Alerts Notice: This company has been marked as potentially delisted and may not be actively trading. Add Compare Share Share Short InterestStock AnalysisCompetitorsHeadlinesSocial MediaStock AnalysisCompetitorsHeadlinesSocial Media Purple Biotech Short Interest DataCurrent Short Volume13,300 sharesPrevious Short Volume44,000 sharesChange Vs. Previous Month-69.77%Dollar Volume Sold Short$56,126.00Short Interest Ratio / Days to Cover0.0Last Record DateNovember 30, 2020Outstanding Shares15,725,000 sharesPercentage of Shares Shorted0.08%Today's Trading Volume270,939 sharesAverage Trading Volume1,176,304 sharesToday's Volume Vs. Average23% Short Selling Purple Biotech ? Sign up to receive the latest short interest report for Purple Biotech and its competitors with MarketBeat's FREE newsletter. Email Address Skip Charts & View Short Interest HistoryShort InterestDays to CoverShort Percent of FloatKTOV Short Interest Over TimeKTOV Days to Cover Over TimeKTOV Percentage of Float Shorted Over Time Ad Crypto Swap ProfitsHe Is Giving Away BitcoinAnd my special guest is willing to give you $10 in Bitcoin (BTC) if you take it seriously. Right now is a very important time to pay attention to what we are doing and what is happening. If you wait... it will be too late. This week we are holding several workshops and if you attend and pay attention my special guest is going to send you $10 in Bitcoin.>> Register right here Purple Biotech Short Interest History Export to ExcelReport DateTotal Shares Sold ShortDollar Volume Sold ShortChange from Previous ReportPercentage of Float ShortedDays to CoverPrice on Report Date 11/30/202013,300 shares $56,126.00 -69.8%N/A0 $4.22 11/15/202044,000 shares $182,600.00 -7.2%N/A0.1 $4.15 10/30/202047,400 shares $203,346.00 -74.2%N/A0 $4.29 10/15/2020183,700 shares $791,747.00 -33.7%N/A0 $4.31 9/30/2020277,100 shares $1.22 million -31.1%N/A0 $4.41 9/15/2020402,000 shares $1.74 million -37.5%N/A0 $4.34 Get the Latest News and Ratings for KTOV and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Purple Biotech and its competitors with MarketBeat's FREE daily newsletter. 8/31/2020643,400 shares $2.79 million -83.2%N/A0 $4.34 8/14/20203,820,000 shares $20.15 million -72.3%N/A0.1 $5.27 7/31/202013,770,000 shares $110.53 million -3.5%N/A0.4 $8.03 7/15/202014,270,000 shares $103.46 million +118.9%N/A0.4 $7.25 6/30/20206,520,000 shares $72.37 million +37.0%N/A0.2 $11.10 6/15/20204,760,000 shares $22.51 million -29.5%N/A0.2 $4.73 5/29/20206,750,000 shares $31.79 million +163.7%N/A0.5 $4.71 5/15/20202,560,000 shares $12.57 million +806.5%N/A0.2 $4.91 4/30/2020282,400 shares $946,040.00 -54.8%N/A0 $3.35 4/15/2020625,200 shares $2.19 million +73.5%N/A0.3 $3.50 3/31/2020360,300 shares $1.10 million -61.2%N/A0.3 $3.06 3/13/2020927,600 shares $2.13 million +3.6%N/A3 $2.30 2/28/2020895,700 shares $5.37 million -11.3%N/A5.8 $6.00 2/14/20201,010,000 shares $7.58 million +13.9%N/A7.3 $7.50 1/31/2020886,700 shares $6.47 million +25.4%N/A7.1 $7.30 1/15/2020707,000 shares $5.87 million +3.2%N/A5.6 $8.30 12/31/2019685,300 shares $5.28 million +287.6%N/A7.9 $7.70 KTOV Short Interest - Frequently Asked Questions What is Purple Biotech's current short interest? Short interest is the volume of Purple Biotech shares that have been sold short but have not yet been closed out or covered. As of November 30th, investors have sold 13,300 shares of KTOV short. Learn More on Purple Biotech's current short interest. Is Purple Biotech's short interest increasing or decreasing? Purple Biotech saw a drop in short interest in the month of November. As of November 30th, there was short interest totaling 13,300 shares, a drop of 69.8% from the previous total of 44,000 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are betting that its price will decline in the future. An increase in short sale volume suggests bearish (negative) sentiment among investors. A decrease on short sale volume suggests bullish (positive) sentiment. How does Purple Biotech's short interest compare to its competitors? Here is how the short interest of companies in the sector of "medical" compare to Purple Biotech: Lixte Biotechnology Holdings, Inc. (0.97%), ASLAN Pharmaceuticals Limited (0.73%), Biofrontera Inc. (0.95%), TFF Pharmaceuticals, Inc. (3.44%), Bionomics Limited (3.17%), Chemomab Therapeutics Ltd. (1.87%), Pasithea Therapeutics Corp. (1.17%), Kineta, Inc. (0.82%), Hepion Pharmaceuticals, Inc. (1.47%), eFFECTOR Therapeutics, Inc. (10.72%), Which stocks are the most shorted right now? As of the most recent reporting period, the following stocks had the largest short interest positions: Charter Communications, Inc. ($4.79 billion), Aon plc ($4.20 billion), Analog Devices, Inc. ($3.66 billion), Moderna, Inc. ($3.51 billion), Uber Technologies, Inc. ($3.24 billion), Snap Inc. ($3.07 billion), The Clorox Company ($2.65 billion), The Kroger Co. ($2.24 billion), International Flavors & Fragrances Inc. ($2.08 billion), and Expedia Group, Inc. ($1.86 billion). View all of the most shorted stocks. What does it mean to sell short Purple Biotech stock? Short selling KTOV is an investing strategy that aims to generate trading profit from Purple Biotech as its price is falling. KTOV shares are trading up $0.02 today. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit. How does a short squeeze work against Purple Biotech? A short squeeze for Purple Biotech occurs when it has a large amount of short interest and its stock appreciates in price. This forces short sellers to cover their short interest positions by buying actual shares of KTOV, which in turn drives the price of the stock up even further. How often is Purple Biotech's short interest reported? Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including KTOV, twice per month. The most recent reporting period available is November, 30 2020. More Short Interest Resources from MarketBeat Related Companies: LIXT Short Interest ASLN Short Interest BFRI Short Interest TFFP Short Interest BNOX Short Interest CMMB Short Interest KTTA Short Interest KA Short Interest HEPA Short Interest EFTR Short Interest Short Interest Tools: Stocks to Short Largest Short Interest Positions Short Interest Increases Short Interest Decreases Short Interest Reporting Dates This page (NASDAQ:KTOV) was last updated on 4/25/2024 by MarketBeat.com Staff From Our PartnersThe Best AI Stock to Own in the World Today is Trading for Just $25Banyan Hill PublishingThis Apple-like Innovator is Revolutionizing HealthcareWall Street StarHe Is Giving Away BitcoinCrypto Swap ProfitsYour Money is Not SafeAmerican AlternativeBitcoin Rockets To Record High But Buy THIS InsteadParadigm Presstop AI stock (it’s not MSFT, GOOGL, AMZN or AAPL)Traders AgencyRed Alert: Your Money's Disappearance Act - Banks' Greed Unleashed!Priority GoldThe #1 Crypto for 2024InvestorPlace